Cambridge-based Compass Therapeutics raising $120M for antibody discovery work
Compass Therapeutics, formed by leadership at fellow antibody discovery company Adimab, is raising $120 million.
compass therapeutics
Compass Therapeutics, formed by leadership at fellow antibody discovery company Adimab, is raising $120 million.